S. Karlsson, H.-E. Högberg
FULL PAPER
(s, 1 H), 3.71 (d, J ϭ 10.9 Hz, 1 H), 4.47Ϫ4.52 (m, 1 H), 7.25Ϫ7.40
(31), 91 (100). C15H21NO2 (247.33): calcd. C 72.8, H 8.6, N 5.7;
(m, 5 H) ppm. 13C NMR (CDCl3): δ ϭ 25.4, 30.6, 35.1, 43.8, 64.1, found C 72.8, H 8.6, N 5.8.
66.2, 77.7, 85.1, 127.4, 128.1, 128.3, 137.5 ppm. MS (EI): m/z (%) ϭ
233 (63) [Mϩ], 216 (2), 134 (100). C14H19NO2 (233.31): calcd. C
72.1, H 8.2, N 6.0; found C 72.3, H 8.1, N 5.9.
[(3R,3aR,6aR)-3-Cyclopropyl-2,5,5-trimethylhexahydro-3aH-cyclo-
penta[d]isoxazol-3a-yl]methanol (5d): 48% ee. M.p. 41Ϫ42 °C.
[α]2D5 ϭ Ϫ55.0 (c ϭ 0.96, CHCl3). 1H NMR (CDCl3): δ ϭ
0.16Ϫ0.34 (m, 2 H), 0.51Ϫ0.71 (m, 2 H), 0.80Ϫ0.95 (m, 1 H), 1.03
(s, 3 H), 1.15 (s, 3 H), 1.40 (d, J ϭ 13.6 Hz, 1 H), 1.48 (d, J ϭ
13.6 Hz, 1 H), 1.64 (dd, J ϭ 4.5, 13.6 Hz, 1 H), 1.72 (d, J ϭ 8.3 Hz,
1 H), 1.78 (dd, J ϭ 6.3, 13.6 Hz, 1 H), 2.72 (s, 3 H), 3.52 (s, OH),
3.63 (d, J ϭ 10.5 Hz, 1 H), 3.98 (d, J ϭ 10.5 Hz, 1 H), 4.58 (dd,
J ϭ 4.5, 6.3 Hz, 1 H) ppm. 13C NMR (CDCl3): δ ϭ Ϫ0.4, 4.1, 7.0,
30.1, 30.5, 42.1, 43.5, 46.2, 47.7, 63.0, 66.8, 84.1, 86.1 ppm. MS
(EI): m/z (%) ϭ 225 (34) [Mϩ], 184 (10), 100 (100), 84 (82).
C13H23NO2 (225.33): calcd. C 69.3, H 10.3, N 6.2; found C 69.1,
H 10.2, N 6.1.
[(3R,3aR,6aR)-3-(Cyclopent-1-en-1-yl)-2-methylhexahydro-3aH-
cyclopenta[d]isoxazol-3a-yl]methanol (3b): Ͼ 99% ee. M.p. 123Ϫ125
°C. [α]2D0 ϭ Ϫ155 (c ϭ 0.51, CHCl3) 1H NMR (CDCl3): δ ϭ
1.35Ϫ1.99 (m, 8 H), 2.23Ϫ2.48 (m, 5 H), 2.58 (s, 3 H), 2.74 (s, 1
H), 3.43 (dd, J ϭ 6.1, 11.0 Hz, 1 H), 3.60 (dd, J ϭ 3.5, 11.0 Hz, 1
H), 4.40 (d, J ϭ 5.4 Hz, 1 H), 5.66Ϫ5.70 (m, 1 H) ppm. 13C NMR
(CDCl3): δ ϭ 23.0, 24.0, 31.8, 32.4, 33.6, 34.8, 43.3, 63.1, 65.7,
78.1, 85.3, 127.6, 139.1 ppm. MS (EI): m/z (%) ϭ 223 (40) [Mϩ],
125 (50), 68 (100). C13H21NO2 (223.31): calcd. C 69.9, H 9.5, N
6.3; found C 69.8, H 9.6, N 6.2.
[(3S,3aR,6aR)-3-(Cyclopent-1-en-1-yl)-2-methylhexahydro-3aH-
cyclopenta[d]isoxazol-3a-yl]methanol (4b): ee not determined. 1H
NMR (CDCl3): δ ϭ 1.23Ϫ1.93 (m, 9 H), 2.13Ϫ2.41 (m, 4 H), 2.60
(s, 3 H), 3.00 (s, 1 H), 3.60 (d, J ϭ 10.8 Hz, 1 H), 3.69 (d, J ϭ
10.8 Hz, 1 H), 4.37 (t, J ϭ 4.6 Hz, 1 H), 5.60Ϫ5.66 (m, 1 H) ppm.
13C NMR (CDCl3): δ ϭ 23.3, 25.6, 30.7, 32.3, 34.7, 34.8, 44.3,
63.4, 67.0, 75.3, 85.2, 127.9, 139.7 ppm. MS (EI): m/z (%) ϭ 223
(55) [Mϩ], 125 (42), 68 (100).
[(1R,2R)-2-Acetoxy-1-{(R)-[acetyl(methyl)amino](phenyl)-
methyl}cyclopentyl]methyl Acetate (23): Compound 3a (434 mg,
1.86 mmol; 91% ee, Ͼ 98% de), 20% Pd(OH)2/C (100 mg) and HCl
(37% aq.; 0.3 mL) in MeOH (10 mL) were stirred under hydrogen
at ambient pressure and room temperature overnight. The suspen-
sion was filtered, rinsed with MeOH, followed by concentration.
To the resulting amino diol were added pyridine (1.5 g) and CH2Cl2
(25 mL), followed by dropwise addition of AcCl (1.5 g). After 1 h,
HCl (2 ; 30 mL) and EtOAc (50 mL) were added. The organic
phase was extracted with NaHCO3 (aq. satd.; 30 mL), dried
(Na2SO4) and concentrated. The residue was purified by flash chro-
matography [SiO2; EtOAc/cyclohexane (0 Ǟ 100%)] to give the title
compound (612 mg, 1.69 mmol) as an oil in 98% purity (GC).
[(3R,3aR,6aR)-2-Methyl-3-propylhexahydro-3aH-cyclopenta[d]-
isoxazol-3a-yl]methanol (3c): 57% ee. B.p. 120 °C/0.9 mbar. [α]D25
ϭ
Ϫ58.3 (c ϭ 0.82, CHCl3). 1H NMR (CDCl3): δ ϭ 0.98 (t, J ϭ
7.0 Hz, 3 H), 1.22Ϫ1.91 (m, 10 H), 2.11Ϫ2.18 (m, 1 H), 2.59 (s, 3
H), 3.21 (s, OH), 3.45 (d, J ϭ 10.6 Hz, 1 H), 3.85 (d, J ϭ 10.6 Hz,
1 H), 4.43 (d, J ϭ 5.7 Hz, 1 H) ppm. 13C NMR (CDCl3): δ ϭ 14.6,
20.4, 24.2, 28.7, 31.7, 33.1, 42.9, 61.7, 65.2, 76.0, 85.3 ppm. MS
(EI): m/z (%) ϭ 199 (14) [Mϩ], 156 (100), 102 (39). C11H21NO2
(199.29): calcd. C 66.3, H 10.6, N 7.0; found C 66.2, H 10.7, N 6.9.
1
[α]2D5 ϭ Ϫ75.2 (c ϭ 0.39, CHCl3). H NMR [(CD3)2SO; * denotes
peaks arising from a minor rotamer]: δ ϭ 1.35Ϫ2.18 (m, 7.8 H),
1.76 (s, 2.4 H), 1.93 (s, 2.4 H), 1.98 (s, 2.4 H), 2.93 (s, 3 H), 3.84
(d, J ϭ 12.0 Hz, 1 H), 4.02* (d, J ϭ 11.9 Hz, 0.2 H), 4.10 (d, J ϭ
12.0 Hz, 0.8 H), 5.12Ϫ5.19 (m, 1 H), 5.25* (s, 0.2 H), 6.05 (s, 0.8
H), 7.21Ϫ7.50 (m, 5 H) ppm. 13C NMR (CDCl3; * denotes peaks
arising from a minor rotamer]: δ ϭ 20.8*, 20.9, 21.1, 21.2, 22.0*,
22.4, 30.9, 31.0*, 31.7, 34.1, 52.6*, 52.9, 57.4, 62.9*, 65.7, 67.0*,
79.1, 79.7*, 127.1, 127.6*, 128.2, 128.5*, 128.6*, 129.4, 138.8*,
139.2, 169.8*, 170.3*, 170.4, 170.8, 171.1, 171.4* ppm. MS (EI):
m/z (%) ϭ 361 (8) [Mϩ], 302 (10), 162 (70), 120 (100). C20H27NO5
(361.43): calcd. C 66.5, H 7.5, N 3.9; found C 66.7, H 7.6, N 3.9.
[(3R,3aR,6aR)-3-Cyclopropyl-2-methylhexahydro-3aH-cyclo-
penta[d]isoxazol-3a-yl]methanol (3d): 41% ee. M.p. 83Ϫ85 °C.
[α]2D5 ϭ Ϫ41.4 (c ϭ 0.86, CHCl3). 1H NMR (CDCl3): δ ϭ
0.15Ϫ0.24 (m, 1 H), 0.29Ϫ0.38 (m, 1 H), 0.53Ϫ0.70 (m, 2 H),
0.86Ϫ1.00 (m, 1 H), 1.27Ϫ1.84 (m, 7 H), 2.67 (s, 3 H), 2.83 (s,
OH), 3.60 (d, J ϭ 10.5 Hz, 1 H), 3.96 (d, J ϭ 10.5 Hz, 1 H), 4.40
(d, J ϭ 5.5 Hz, 1 H) ppm. 13C NMR (CDCl3): δ ϭ Ϫ0.2, 3.9, 7.2,
23.9, 31.7, 33.5, 43.2, 62.5, 66.1, 81.7, 85.1 ppm. MS (EI): m/z
(%) ϭ 197 (33) [Mϩ], 156 (20), 100 (87), 84 (100). C11H19NO2
(197.27): calcd. C 67.0, H 9.7, N 7.1; found C 67.0, H 9.6, N 7.1.
(1R,2R)-2-Benzyl-2-(hydroxymethyl)cyclopentanol (24) by Re-
duction of 23: To a cold (0 °C) suspension of LiAlH4 (0.48 g,
12.7 mmol) in dry THF (10 mL), compound 23 (460 mg,
1.27 mmol; 91% ee, Ͼ 98% de) was added, dissolved in dry THF
(10 mL). The reaction mixture was then allowed to reach room
temperature. After 0.5 h, water (0.53 mL) and NaOH (aq. 15%,
0.53 mL) were added, followed by the addition of water (1.6 mL).
The resulting suspension was filtered, the solid rinsed with EtOAc
and the filtrate concentrated. The resulting amino diol was dis-
solved in MeOH (5 mL). 10% Pd/C (100 mg) was added, followed
by stirring under hydrogen at ambient pressure and room tempera-
ture overnight. Filtration, followed by concentration furnished the
crude diol 24. Flash chromatography [SiO2; EtOAc/cyclohexane (0
Ǟ 100%)] gave the title compound as colorless crystals in Ͼ 99%
(3S,3aR,6aR)-3a-(Hydroxymethyl)-2-methylhexahydro-2H-cyclo-
penta[d]isoxazole-3-carbaldehyde (3e): 53% ee. M.p. 86Ϫ88 °C.
[α]2D5 ϭ Ϫ93.5 (c ϭ 0.51, CHCl3). 1H NMR (CDCl3): δ ϭ 1.35Ϫ2.05
(m, 7 H), 2.60 (s, 3 H), 3.36 (s, 1 H), 3.47 (d, J ϭ 11.4 Hz, 1 H),
3.52 (d, J ϭ 11.4 Hz, 1 H), 4.49 (d, J ϭ 5.4 Hz, 1 H), 6.37Ϫ6.43
(m, 2 H), 7.44Ϫ7.47 (m, 1 H) ppm. 13C NMR (CDCl3): δ ϭ 23.8,
31.8, 33.4, 43.2, 63.8, 65.6, 75.8, 85.8, 108.6, 110.6, 142.7, 149.6
ppm. MS (EI): m/z (%) ϭ 223 (25) [Mϩ], 125 (100). C12H17NO3
(223.27): calcd. C 64.6, H 7.7, N 6.3; found C 64.5, H 7.8, N 6.2.
[(3R,3aR,6aR)-2-Benzyl-3-methylhexahydro-3aH-cyclopenta[d]-
isoxazol-3a-yl]methanol (3f): 70% ee. [α]2D5 ϭ Ϫ93.7 (c ϭ 0.83,
CHCl3). H NMR (CDCl3): δ ϭ 1.12Ϫ1.25 (m, 1 H), 1.25 (d, J ϭ purity (GC). M.p. 116Ϫ118 °C. [α]2D5 ϭ Ϫ20.5 (c ϭ 0.62, MeOH).
6.7 Hz, 3 H), 1.45Ϫ1.88 (m, 5 H), 2.50 (q, J ϭ 6.7 Hz, 1 H), 3.00 1H NMR (CDCl3): δ ϭ 0.93Ϫ1.09 (m, 1 H), 1.50Ϫ2.16 (m, 5 H),
(s, OH), 3.44 (d, J ϭ 10.6 Hz, 1 H), 3.62 (d, J ϭ 14.4 Hz, 1 H), 2.23Ϫ2.31 (m, OH), 2.51 (d, J ϭ 13.4 Hz, 1 H), 2.60Ϫ2.65 (m,
3.83 (d, J ϭ 10.6 Hz, 1 H), 4.09 (d, J ϭ 14.4 Hz, 1 H), 4.45 (d, J ϭ OH), 3.10 (d, J ϭ 13.4 Hz, 1 H), 3.27 (dd, J ϭ 3.0, 10.4 Hz, 1 H),
1
5.7 Hz, 1 H), 7.21Ϫ7.40 (m, 5 H) ppm. 13C NMR (CDCl3): δ ϭ
11.3, 23.8, 32.0, 32.3, 59.1, 61.7, 65.6, 68.9, 84.9, 127.2, 128.2, 7.15Ϫ7.35 (m, 5 H) ppm. 13C NMR (CDCl3): δ ϭ 19.2, 29.2, 31.6,
128.6, 137.0 ppm. MS (EI): m/z (%) ϭ 247 (59) [Mϩ], 232 (37), 150
33.0, 49.6, 68.1, 80.1, 125.9, 128.0, 130.5, 139.0 ppm. MS (EI):
3.55 (dd, J ϭ 5.1, 10.4 Hz, 1 H), 4.18 (dt, J ϭ 3.3, 7.4 Hz, 1 H),
2790
2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2003, 2782Ϫ2791